Herewith three items of pandemic news you may have missed recently: Pfizer’s vaccine handles the UK variant just fine; how to go about producing a vaccine-evading coronavirus; and Biden will not hold back second doses. Plus the accustomed frippery. Biden … Continue reading →
Herewith three items of pandemic news you may have missed recently: A particular risk of diabetes with Covid-19; worries of vaccine escape by the South African variant; and the many ideas floated for bolstering vaccine supply. Plus a frippery. Ways … Continue reading →
Not only has the UK approved the AstraZeneca / Oxford vaccine candidate, on what many specialists consider thin evidence from a bungled trial, they are embarking on a grand epidemiological experiment: seeing how well covering more people with a single … Continue reading →
Herewith three items of pandemic news you may have missed recently: FDA investigating allergic reactions to the first vaccine; the susceptibility of pigs; and the give-and-take among sleep, melatonin, and Covid-19. Plus the usual frippery. Sleep The Atlantic has a … Continue reading →
A CDC advisory committee has issued its recommendation for prioritizing who is next to receive scarce Covid-19 vaccines. Those over 75 and some first responders are up next, followed by over-65s, more essential workers, and younger adults with preconditions. The … Continue reading →
Herewith three items of pandemic news you may have missed recently: A wild mink in Utah has turned up infected; and two possibilities for finding that we may have more vaccine than we thought we did. Plus two fripperies. Just … Continue reading →
The first doses of the Pfizer / BioNTech vaccine are on the move. By year’s end, states should receive about 3/4 of the amount they will need to give the highest priority people the first of their two shots. The … Continue reading →
